Your browser doesn't support javascript.
loading
Influenza vaccination of cancer patients during PD-1 blockade induces serological protection but may raise the risk for immune-related adverse events.
Läubli, Heinz; Balmelli, Catharina; Kaufmann, Lukas; Stanczak, Michal; Syedbasha, Mohammedyaseen; Vogt, Dominik; Hertig, Astrid; Müller, Beat; Gautschi, Oliver; Stenner, Frank; Zippelius, Alfred; Egli, Adrian; Rothschild, Sacha I.
Afiliação
  • Läubli H; Department of Internal Medicine, Division of Medical Oncology, University Hospital Basel, Basel, Switzerland.
  • Balmelli C; Cancer Immunology, Department of Biomedicine, University of Basel, Basel, Switzerland.
  • Kaufmann L; Department of Internal Medicine, Division of Medical Oncology, University Hospital Basel, Basel, Switzerland.
  • Stanczak M; Applied Microbiology Research, Department of Biomedicine, University of Basel, Basel, Switzerland.
  • Syedbasha M; Cancer Immunology, Department of Biomedicine, University of Basel, Basel, Switzerland.
  • Vogt D; Applied Microbiology Research, Department of Biomedicine, University of Basel, Basel, Switzerland.
  • Hertig A; Applied Microbiology Research, Department of Biomedicine, University of Basel, Basel, Switzerland.
  • Müller B; Department of Internal Medicine, Division of Medical Oncology, University Hospital Basel, Basel, Switzerland.
  • Gautschi O; Oncology, Cantonal Hospital Lucerne, Lucerne, Switzerland.
  • Stenner F; Oncology, Cantonal Hospital Lucerne, Lucerne, Switzerland.
  • Zippelius A; Department of Internal Medicine, Division of Medical Oncology, University Hospital Basel, Basel, Switzerland.
  • Egli A; Cancer Immunology, Department of Biomedicine, University of Basel, Basel, Switzerland.
  • Rothschild SI; Department of Internal Medicine, Division of Medical Oncology, University Hospital Basel, Basel, Switzerland.
J Immunother Cancer ; 6(1): 40, 2018 05 22.
Article em En | MEDLINE | ID: mdl-29789020
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Contexto em Saúde: 2_ODS3 / 6_ODS3_enfermedades_notrasmisibles Problema de saúde: 2_enfermedades_transmissibles / 2_muertes_prematuras_enfermedades_notrasmisibles / 6_other_respiratory_diseases Assunto principal: Vacinação / Influenza Humana / Receptor de Morte Celular Programada 1 / Neoplasias Tipo de estudo: Clinical_trials / Etiology_studies / Risk_factors_studies Limite: Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: J Immunother Cancer Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Suíça
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Contexto em Saúde: 2_ODS3 / 6_ODS3_enfermedades_notrasmisibles Problema de saúde: 2_enfermedades_transmissibles / 2_muertes_prematuras_enfermedades_notrasmisibles / 6_other_respiratory_diseases Assunto principal: Vacinação / Influenza Humana / Receptor de Morte Celular Programada 1 / Neoplasias Tipo de estudo: Clinical_trials / Etiology_studies / Risk_factors_studies Limite: Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: J Immunother Cancer Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Suíça